-
News | 2023.11.16
Antibiotic resistance, or how bacteria become resistant
Antibiotic resistance is a major public health issue. Understanding how resistance works and how bacteria become resistant is crucial in helping us maintain the effectiveness of antibiotics against bacteria.
-
News | 2023.11.24
The Institut Pasteur & Kyoto University have signed a LOI to establish the Pasteur Aging Research Center
Professor Stewart Cole, President of the Institut Pasteur and Professor Nagahiro Minato, President of the Kyoto University signed a Letter of Intent (LOI) to create the Pasteur Aging Research Center (“PARC”) in Japan. This Letter of Intent is yet another step on the path to the creation of the Institut Pasteur of Japan (IPJ), as the PARC will become one of the research centers of the Institut...
-
News | 2023.11.27
The spin-off Oncovita wins the France 2030 call for projects
Oncovita, a spin-off from the Institut Pasteur, has won the call for projects "Innovation in biotherapies and bioproduction" as part of the France 2030 investment plan. The company will receive €4.5 million in funding from Bpifrance to support the development of its immunotherapeutic cancer vaccine, MVdeltaC. The company will also benefit from €3.5 million in private funding. This...
-
Vidéo | 2023.11.28
All about HIV/AIDS with Michaela Müller-Trutwin
Although there have been considerable advances in treatment, HIV continues to be a serious problem, especially in the terminal phase of the disease in the absence of treatment, known as AIDS. HIV/AIDS is currently one of the leading causes of death worldwide for adolescents and women of childbearing age.Michaela Müller-Trutwin, Head of HIV, Inflammation and Persistence Unit (Institut Pasteur...
-
Document de presse | 2023.11.14
Odette Tomescu-Hatto appointed Institut Pasteur Executive Vice-President, International Affairs
Dr. Odette Tomescu-Hatto has been appointed Executive Vice-President, International Affairs at the Institut Pasteur, with effect from January 2024.Following the meeting of the Board of Governors on October 11, 2023, Dr. Odette Tomescu-Hatto was appointed Executive Vice-President, International Affairs at the Institut Pasteur, with effect from January 2024.Dr. Odette Tomescu-Hatto holds a PhD in...
-
Document de presse | 2023.11.23
How does neonatal listeriosis impact children's health?
Maternal-fetal listeriosis is a severe disease that can lead to miscarriage, premature birth or serious neonatal infection. But what are the long-term consequences of neonatal listeriosis on the health of surviving infants? For the first time, a team of scientists and physicians from the Institut Pasteur, Université Paris Cité, the Paris Public Hospital Network (AP-HP) and Inserm monitored the...
-
Document de presse | 2023.12.01
40 years after the discovery of HIV, research raises hopes of remission
Nearly 39 million people worldwide are carriers of human immunodeficiency virus (HIV), and 1.3 million people contracted HIV in 2022[1]. Forty years after the virus was discovered at the Institut Pasteur, HIV research is still active – the aim is to elucidate the mechanisms of infection so that the virus can be eradicated. A concerted global effort has led to considerable progress in knowledge....
-
Document de presse | 2023.12.06
Plasmodium vivax malaria: infections may be largely underestimated in sub-Saharan Africa
Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University Hospital, in collaboration with King's College London, UK, the Institut Pasteur (Paris, France), the Institut Pasteur de Madagascar and the University of Addis Ababa, Ethiopia, have revealed how...
-
Article | 2023.12.07
University of Alicante
The Erasmus + Internships Programme gives the students at any study cycle and recent graduates of the University of Alicante the opportunity of undertaking a working experience in companies, institutions and organizations located in another country member of the EU.The project of Pasteur will address students at any study cycle and recent graduates of our Faculty of Sciences, detailed on...
-
Document de presse | 2023.12.05
COVID-19: the persistence of SARS-CoV-2 in the lungs and the role of innate immunity
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut Pasteur specialized in HIV, in collaboration with a French public research institute, the Alternative Energies and Atomic Energy Commission (CEA), conducted a study on lung...
